Cargando…

Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group

BACKGROUND: Myocardial infarction (MI) as a term for a heart attack happens due to reduced blood flow to heart myocardium and lack of oxygen supply caused by plaques in the interior walls of coronary arteries. With respect to the importance of MI etiology, we aimed to study the relationship of MI an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shamshirian, Amir, Alizadeh-Navaei, Reza, Abedi, Samira, Jafarpour, Hamed, Fazli, Hanieh, Hosseini, Samira, Hessami, Amirhossein, Karimifar, Keyvan, Yosefi, Sedighe, Zahedi, Mohammad, Motamen, Sepideh, Ghorbanpour, Atiyeh, Zarandi, Bahman, Esfahani, Aliakbar, Rostamian-Moghaddam, Yeganeh, Mehdipour, Shirin, Heydari, Keyvan, Aghajanian, Sedigheh, Mehdi, Somayeh Pour, Azad, Alireza, Azizi, Soheil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research and Publications Office of Jimma University 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036464/
https://www.ncbi.nlm.nih.gov/pubmed/32116427
http://dx.doi.org/10.4314/ejhs.v30i1.2
_version_ 1783500224283541504
author Shamshirian, Amir
Alizadeh-Navaei, Reza
Abedi, Samira
Jafarpour, Hamed
Fazli, Hanieh
Hosseini, Samira
Hessami, Amirhossein
Karimifar, Keyvan
Yosefi, Sedighe
Zahedi, Mohammad
Motamen, Sepideh
Ghorbanpour, Atiyeh
Zarandi, Bahman
Esfahani, Aliakbar
Rostamian-Moghaddam, Yeganeh
Mehdipour, Shirin
Heydari, Keyvan
Aghajanian, Sedigheh
Mehdi, Somayeh Pour
Azad, Alireza
Azizi, Soheil
author_facet Shamshirian, Amir
Alizadeh-Navaei, Reza
Abedi, Samira
Jafarpour, Hamed
Fazli, Hanieh
Hosseini, Samira
Hessami, Amirhossein
Karimifar, Keyvan
Yosefi, Sedighe
Zahedi, Mohammad
Motamen, Sepideh
Ghorbanpour, Atiyeh
Zarandi, Bahman
Esfahani, Aliakbar
Rostamian-Moghaddam, Yeganeh
Mehdipour, Shirin
Heydari, Keyvan
Aghajanian, Sedigheh
Mehdi, Somayeh Pour
Azad, Alireza
Azizi, Soheil
author_sort Shamshirian, Amir
collection PubMed
description BACKGROUND: Myocardial infarction (MI) as a term for a heart attack happens due to reduced blood flow to heart myocardium and lack of oxygen supply caused by plaques in the interior walls of coronary arteries. With respect to the importance of MI etiology, we aimed to study the relationship of MI and blood examination variables. METHODS: This study was conducted in Mazandaran Heart Center as a hospital-based case-control Comprising 894 participants including 465 cases and 429 controls, individually matched by sex and age. Considered blood markers were analyzed using routine laboratory methods and equipment. RESULTS: Of all participants, 64.3% of the cases and 51.0% of the controls were males with a mean age of 61.2 (±13.8) in cases and 62.4 (±14.) in controls. We could not find any differences between cases and controls for total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and alkaline-phosphatase (ALP) (P>0.05). However, levels of creatine-kinase-muscle/brain (CK-MB) (P<0.0001), fasting-blood-sugar (FBS) (P<0.0001), aspartate-aminotransferase (AST) (P<0.0001), alanine-transferase (ALT) (P<0.0001) and erythrocyte sedimentation rate (ESR) (P=0.001) were significantly higher in cases compared to the controls (P<0.05). Multivariable analyses revealed that the risk of MI was associated with high levels of AST (adjusted OR=24.3, 95%CI=3.5±165.6, P=0.001) and LDL (adjusted OR=7.4, 95%CI=1.0±51.8, P=0.001). CONCLUSION: Our investigation indicated that the levels of CK-MB, FBS, AST, ALT and ESR were significantly higher in patients with MI. Besides, our findings showed that the risk of MI in cases with high levels of AST and LDL was about 24 and 7 times more than the control group respectively.
format Online
Article
Text
id pubmed-7036464
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Research and Publications Office of Jimma University
record_format MEDLINE/PubMed
spelling pubmed-70364642020-02-28 Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group Shamshirian, Amir Alizadeh-Navaei, Reza Abedi, Samira Jafarpour, Hamed Fazli, Hanieh Hosseini, Samira Hessami, Amirhossein Karimifar, Keyvan Yosefi, Sedighe Zahedi, Mohammad Motamen, Sepideh Ghorbanpour, Atiyeh Zarandi, Bahman Esfahani, Aliakbar Rostamian-Moghaddam, Yeganeh Mehdipour, Shirin Heydari, Keyvan Aghajanian, Sedigheh Mehdi, Somayeh Pour Azad, Alireza Azizi, Soheil Ethiop J Health Sci Original Article BACKGROUND: Myocardial infarction (MI) as a term for a heart attack happens due to reduced blood flow to heart myocardium and lack of oxygen supply caused by plaques in the interior walls of coronary arteries. With respect to the importance of MI etiology, we aimed to study the relationship of MI and blood examination variables. METHODS: This study was conducted in Mazandaran Heart Center as a hospital-based case-control Comprising 894 participants including 465 cases and 429 controls, individually matched by sex and age. Considered blood markers were analyzed using routine laboratory methods and equipment. RESULTS: Of all participants, 64.3% of the cases and 51.0% of the controls were males with a mean age of 61.2 (±13.8) in cases and 62.4 (±14.) in controls. We could not find any differences between cases and controls for total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and alkaline-phosphatase (ALP) (P>0.05). However, levels of creatine-kinase-muscle/brain (CK-MB) (P<0.0001), fasting-blood-sugar (FBS) (P<0.0001), aspartate-aminotransferase (AST) (P<0.0001), alanine-transferase (ALT) (P<0.0001) and erythrocyte sedimentation rate (ESR) (P=0.001) were significantly higher in cases compared to the controls (P<0.05). Multivariable analyses revealed that the risk of MI was associated with high levels of AST (adjusted OR=24.3, 95%CI=3.5±165.6, P=0.001) and LDL (adjusted OR=7.4, 95%CI=1.0±51.8, P=0.001). CONCLUSION: Our investigation indicated that the levels of CK-MB, FBS, AST, ALT and ESR were significantly higher in patients with MI. Besides, our findings showed that the risk of MI in cases with high levels of AST and LDL was about 24 and 7 times more than the control group respectively. Research and Publications Office of Jimma University 2020-01 /pmc/articles/PMC7036464/ /pubmed/32116427 http://dx.doi.org/10.4314/ejhs.v30i1.2 Text en © 2020 Shamshirian A, et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Original Article
Shamshirian, Amir
Alizadeh-Navaei, Reza
Abedi, Samira
Jafarpour, Hamed
Fazli, Hanieh
Hosseini, Samira
Hessami, Amirhossein
Karimifar, Keyvan
Yosefi, Sedighe
Zahedi, Mohammad
Motamen, Sepideh
Ghorbanpour, Atiyeh
Zarandi, Bahman
Esfahani, Aliakbar
Rostamian-Moghaddam, Yeganeh
Mehdipour, Shirin
Heydari, Keyvan
Aghajanian, Sedigheh
Mehdi, Somayeh Pour
Azad, Alireza
Azizi, Soheil
Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group
title Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group
title_full Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group
title_fullStr Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group
title_full_unstemmed Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group
title_short Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group
title_sort levels of blood biomarkers among patients with myocardial infarction in comparison to control group
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036464/
https://www.ncbi.nlm.nih.gov/pubmed/32116427
http://dx.doi.org/10.4314/ejhs.v30i1.2
work_keys_str_mv AT shamshirianamir levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT alizadehnavaeireza levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT abedisamira levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT jafarpourhamed levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT fazlihanieh levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT hosseinisamira levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT hessamiamirhossein levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT karimifarkeyvan levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT yosefisedighe levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT zahedimohammad levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT motamensepideh levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT ghorbanpouratiyeh levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT zarandibahman levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT esfahanialiakbar levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT rostamianmoghaddamyeganeh levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT mehdipourshirin levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT heydarikeyvan levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT aghajaniansedigheh levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT mehdisomayehpour levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT azadalireza levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup
AT azizisoheil levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup